AMG 172

Generic Name: AMG 172
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20090515Relapsed/Refractory Renal Cell Carcinoma1A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 172 in Subjects with Relapsed/Refractory Renal Cell Carcinoma.